Furthermore, the identification of equally altered hallmarks and similarly aberrantly expressed genes in both types of cells of ET patients could provide clues about the conserved processes in mature neutrophils, which may be quantitatively o functionally important in the pathogenesis of the disease for patients harboring JAK2 or CALR mutations and ultimately could help develop new therapeutic strategies. The gene discussed is JAK2; the disease is essential thrombocythemia.